Ipilimumab in advanced melanoma: Added benefit for non-pretreated patients not proven

Indirect comparison of individual patient data uncertain and biased, hence results were not interpretable

2014-03-18

(Press-News.org) The German Institute for Quality and Efficiency in Health Care (IQWiG) already assessed the added benefit of ipilimumab in advanced melanoma in 2012. A considerable added benefit was found for patients who had already received previous treatment. In the new dossier compiled by the drug manufacturer, the drug was now compared with the appropriate comparator therapy dacarbazine specified by the Federal Joint Committee (G-BA) also for non-pretreated patients.

Again, the manufacturer claimed a noticeable gain in survival time and thus an added benefit. This time, IQWiG did not concur with the interpretation: The effect was estimated on the basis of an indirect comparison of individual patient data. The data were very uncertain and, moreover, by unilaterally excluding patients with particularly unfavourable prognosis, the effect was biased in favour of ipilimumab. Hence an added benefit of ipilimumab in advanced melanoma for non-pretreated patients is not proven.

Approval expanded

Ipilimumab is a monoclonal antibody used in melanoma if the disease is so advanced that the melanoma can no longer be surgically removed or has formed metastases. In 2012, the manufacturer presented informative data from a randomized controlled trial for pretreated patients. These data indicated a major advantage of ipilimumab in survival time, which was associated with major risk of harm, however.

After the European approval was expanded in 2013 to include patients who have not been treated for their advanced melanoma, the manufacturer now claimed an added benefit versus the appropriate comparator therapy dacarbazine specified by the G-BA also for this group.

Indirect comparison of low quality

However, the manufacturer neither presented a direct comparison nor a so-called adjusted indirect comparison between the study participants who received ipilimumab or the appropriate comparator therapy. Instead, it based its assessment on an indirect comparison of individual patient data from different studies on ipilimumab and on one single study on dacarbazine, from which it chose those patients who had not received previous treatment of advanced melanoma.

It can be assumed in these unadjusted indirect comparisons that patients on both sides of the comparison differ from each other with regards to important confounders, which can entail a systematic bias of the treatment effect. The manufacturer tried to account for these differences with a statistical method.

Results biased in favour of ipilimumab

However, the manufacturer only included those patients in its comparison for whom data on all confounders considered were available. Because of this, considerably more patients were excluded from the comparison on the ipilimumab side than on the dacarbazine side – e.g. 40% compared to not even 1% in the outcome "overall survival". In the outcome "side effects", the numbers were even further apart. Many patients with particularly poor prognosis were apparently excluded from the analysis on the ipilimumab side. The effects were therefore highly biased in favour of ipilimumab.

Analysis did not consider all confounding variables

Furthermore, the manufacturer did not consider known confounders like the presence of visceral metastases, i.e. metastases in internal organs, or the time since the diagnosis of the melanoma in the analysis presented. The certainty of results, which was already low, was further downgraded because of this.

Since the treatment effects presented by the manufacturer were therefore not interpretable, an added benefit of ipilimumab in non-pretreated patients with advanced melanoma is not proven.

G-BA decides on the extent of added benefit

The dossier assessment is part of the overall procedure for early benefit assessments supervised by the G-BA. After publication of the manufacturer's dossier and IQWiG's assessment, the G-BA conducts a commenting procedure, which may provide further information and result in a change to the benefit assessment. The G BA then decides on the extent of the added benefit, thus completing the early benefit assessment.

INFORMATION:

An overview of the results of IQWiG's benefit assessment is given by a German-language executive summary. In addition, the website » http://www.gesundheitsinformation.de, published by IQWiG, provides easily understandable and brief German-language information on ipilimumab.

The G-BA website contains both general English-language information on benefit assessment pursuant to §35a Social Code Book (SGB) V and specific German-language information on the assessment of ipilimumab. More English-language information will be available soon (Sections 2.1 to 2.6 of the dossier assessment as well as subsequently published health information on » http://www.informedhealthonline.org).

If you would like to be informed when these documents are available, please send an e-mail to » info@iqwig.de.

ELSE PRESS RELEASES FROM THIS DATE:

Scientists using UNH detector illuminate cause of sun's 'perfect storm'

2014-03-18

DURHAM, NH –– In a paper published today in Nature Communications, an international team of scientists, including three from the University of New Hampshire's Space Science Center, uncovers the origin and cause of an extreme space weather event that occurred on July 22, 2012 at the sun and generated the fastest solar wind speed ever recorded directly by a solar wind instrument. The formation of the rare, powerful storm showed striking, novel features that were detected by a UNH-built instrument on board NASA's twin-satellite Solar TErrestrial RElations Observatory (STEREO) ...

New airborne GPS technology for weather conditions takes flight

2014-03-18

GPS technology has broadly advanced science and society's ability to pinpoint precise information, from driving directions to tracking ground motions during earthquakes. A new technique led by a researcher at Scripps Institution of Oceanography at UC San Diego stands to improve weather models and hurricane forecasting by detecting precise conditions in the atmosphere through a new GPS system aboard airplanes. The first demonstration of the technique, detailed in the journal Geophysical Research Letters (GRL), is pushing the project's leaders toward a goal of broadly implementing ...

Pitt study challenges accepted sepsis treatment

2014-03-18

PITTSBURGH, Mar.14, 2014 – A structured, standardized approach to diagnose and treat sepsis in its early stages did not change survival chances for people who develop this deadly condition, according to a national, randomized clinical trial led by experts at the University of Pittsburgh School of Medicine. Their findings, available online and published in the May 1 edition of the New England Journal of Medicine, could change the way sepsis is diagnosed and treated. Each year, sepsis, the body's response to severe infections, kills more people than breast cancer, prostate ...

Hold that RT: Much misinformation tweeted after 2013 Boston Marathon bombing

2014-03-18

It takes only a fraction of a second to hit the retweet button on Twitter. But if thousands of people all retweet at once, a piece of information 140 characters long can go viral almost instantly in today's Internet landscape. If that information is incorrect, especially in a crisis, it's hard for the social media community to gain control and push out accurate information, new research shows. University of Washington researchers have found that misinformation spread widely on Twitter after the 2013 Boston Marathon bombing despite efforts by users to correct rumors ...

Satellite movie shows a Mid-Atlantic St. Patrick's Day snow

2014-03-18

The green of St. Patrick's Day in the Mid-Atlantic was covered by white snow as a result of a late winter snow storm. The covering of the green was captured in a movie made at NASA using NOAA's GOES satellite data. The winter storm dropped snow totals from 6" to 12" of snow from Baltimore, Md. to Richmond, Va. The storm arrived during the evening of March 16 and continued through March 17. As of 1 p.m. EDT, light bands of snow continued to fall throughout the Washington, D.C. area. NOAA's GOES-East satellite captured the path the storm took through the Mid-Atlantic ...

Health gap between adult survivors of childhood cancer and siblings widens with age

2014-03-18

Adult survivors of childhood cancer face significant health problems as they age and are five times more likely than their siblings to develop new cancers, heart and other serious health conditions beyond the age of 35, according to the latest findings from the world's largest study of childhood cancer survivors. St. Jude Children's Research Hospital led the research, results of which appear in the March 17 issue of the Journal of Clinical Oncology. The federally funded Childhood Cancer Survivor Study (CCSS) found that the health gap between survivors and their siblings ...

'Breaking bad': Insect pests in the making

2014-03-18

Of thousands of known species of Drosophila fruit flies, just one is known as a crop pest, depositing eggs inside ripening fruit so its maggots can feed and grow. New research from the University of California, Davis, shows the similarities and crucial differences between this pest and its close relatives — and that one related fly has potential to also become a pest. Drosophila flies, found worldwide, lay their eggs in rotting fruit. Drosophila suzukii, also referred to as "spotted-wing Drosophila" because the male has large black blotches on his wings (as do males of ...

UT Arlington information systems professors determine successful software programming aids

2014-03-18

The success of having software programmers work in pairs greatly depends on the ability level of those individual programmers, two UT Arlington College of Business professors have written in a recently released paper. The paper also concluded that using design patterns can greatly improve the quality of software programs and the productivity of programmers. Professor Radha Mahapatra and Associate Professor Sridhar Nerur, both in the Information Systems and Operations Management Department of the College of Business, recently published "Distributed Cognition in Software ...

The basis of a new bioinsecticide is developed to control a pest of banana plantations

2014-03-18

Certain micro-organisms can constitute the active matter to develop bioinsecticides used for pest control. In this case, the researcher used a virus of the baculovirus family, which specifically infect invertebrates and naturally regulate the population of insects of this type on the ground. "We selected a virus that displayed the best insecticidal characteristics," she explained. "Using this virus we developed a large-scale production system by means of which we could treat a surface area equivalent to that of a football pitch using just two larvae." When a larva infected ...

Nanotube composites increase the efficiency of next generation of solar cells

2014-03-18

Carbon nanotubes are becoming increasingly attractive for photovoltaic solar cells as a replacement to silicon. Researchers at Umeå University in Sweden have discovered that controlled placement of the carbon nanotubes into nano-structures produces a huge boost in electronic performance. Their groundbreaking results are published in the prestigious journal Advanced Materials. Carbon nanotubes, CNTs, are one dimensional nanoscale cylinders made of carbon atoms that possess very unique properties. For example, they have very high tensile strength and exceptional electron ...

Ipilimumab in advanced melanoma: Added benefit for non-pretreated patients not proven

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: